COVID-19-induced urological pathologies, a review of the literature based on an observation of Peyronie's disease

Back
Nathan Wirtzfeld*, Gwenola Mambour**, Bertrand Tombal***, Annabelle Stainier*, Roland Vaesen*, Frédéric Leduc* Published in the journal : April 2022 Category : Clinical Report

Summary :

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by the SARS-CoV-2. This coronavirus proves able to invade endothelial cells, thereby causing systemic inflammation and a blood hypercoagulable state. This systematic review of the literature reports on the various urological disorders observed in the course of COVID-19, starting from a case of Peyronie's disease. Only one case of post-COVID-19 Peyronie's disease has been described in the literature so far. Peyronie's disease should be considered as a possible sequela of COVID-19, and healthcare professionals should inquire about a possible COVID-19 history in patients with Peyronie's disease.

What is already known about the topic?

SARS-CoV-2 is responsible for COVID-19, an emerging infectious disease that can have repercussions on several organs in humans. The urological system can also be affected by COVID-19.

What does this article bring up for us?

This article is a systematic review of the literature, which reports on the various urological disorders observed in the course of COVID-19, starting from a case of post-COVID-19 Peyronie's disease, the only one that has been described in the literature so far.

Key Words

COVID-19, SARS-CoV-2, urology, erectile dysfunction, Peyronie’s disease